Brain circuitry of compulsivity and impulsivity

CNS Spectrums

Volumn 19, Issue 1, 2014, Pages 21-27

  Grant, Jon E ^a   Kim, Suck Won ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cognition; compulsivity; impulsivity; neurobiology; neuroimaging

Indexed keywords

ACETYLCYSTEINE; MEMANTINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ANTICIPATION; BRAIN REGION; COMPULSION; CORPUS STRIATUM; DISEASE ASSOCIATION; DRUG EFFECT; EXECUTIVE FUNCTION; HUMAN; IMPULSIVENESS; INFERIOR FRONTAL GYRUS; INHIBITION (PSYCHOLOGY); MEDICAL CARE; NERVE CELL NETWORK; NEUROBIOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PATHOLOGICAL GAMBLING; PERSEVERATION; PRIORITY JOURNAL; REACTION TIME; REVIEW; REWARD; TREATMENT PLANNING; CAUDATE NUCLEUS; COGNITIVE THERAPY; CONNECTOME; ELECTROENCEPHALOGRAM; FUNCTIONAL NEUROIMAGING; LATERAL ORBITAL FRONTAL CORTEX; MEDIAL FRONTAL CORTEX; PREFRONTAL CORTEX; PREMOTOR CORTEX; PSYCHOPHARMACOTHERAPY; PUTAMEN; SUBCORTEX; SUPPLEMENTARY MOTOR AREA;

COMPULSIVE BEHAVIOR; GAMBLING; HUMANS; IMPULSIVE BEHAVIOR; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84896706652     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285291300028X     Document Type: Review

References (70)

1. Fineberg NA, Potenza MN, Chamberlain SR, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010;35(3):591-604.
2. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011;69(4):680-694.
3. Robbins TW, Gillan CM, Smith DG, et al. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012;16(1):81-91.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. text rev. Washington DC: American Psychiatric Association Press; 2000.
5. Moeller FG, Barratt ES, Dougherty DM, et al. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783-1793.
6. Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann. 1993;23:355-358.
7. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-1652.
8. Padhi AK, Mehdi AM, Craig KJ, et al. Current classification of impulse control disorder: neurocognitive and behavioral models of impulsivity and the role of personality. In: Grant JE, Potenza MN, eds. The Oxford Handbook of Impulse Control Disorders. New York: Oxford University Press; 2012:25-46.
9. Bechara A. Impulse control disorders in neurological settings. In: Grant JE, Potenza MN, eds. The Oxford Handbook of Impulse Control Disorders. New York: Oxford University Press; 2012:429-444.
10. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl). 2012;219(2):469-490.
11. Kable JW, Glimcher PW. The neurobiology of decision: consensus and controversy. Neuron. 2009;63(6):733-745.
12. Kable JW, Glimcher PW. An "as soon as possible" effect in human intertemporal decision making: behavioral evidence and neural mechanisms. J Neurophysiol. 2010;103:2513-2531.
13. Monterosso JR, Luo S. An argument against dual valuation system competition: cognitive capacities supporting future orientation mediate rather than compete with visceral motivations. J Neurosci Psychol Econ. 2010;3(1):1-14.
14. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci. 2003;6(2):115-116.
15. Dodds CM, Morein-Zamir S, Robbins TW. Dissociating inhibition, attention, and response control in the frontoparietal network using functional magnetic resonance imaging. Cereb Cortex. 2011;21(5):1155-1165.
16. Harrison BJ, Soriano-Mas C, Pujol J, et al. Altered corticostriatal functional connectivity in obsessivecompulsive disorder. JAMA Psychiatry. 2009;66(11):1189-1200.
17. Brennan BP, Rauch SL, Jensen JE, et al. A critical review of magnetic resonance spectroscopy studies of obsessivecompulsive disorder. Biol Psychiatry. 2013;73(1):24-31.
18. Ting JT, Feng G. Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol. 2011;21(6):842-848.
19. Adler CM, McDonough-Ryan P, Sax KW, et al. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res. 2000;34(4-5):317-324.
20. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. JAMA Psychiatry. 1994;51(1):62-70.
21. Van Den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. JAMA Psychiatry. 2005;62(8):922-933.
22. Fitzgerald KD, Stern ER, Angstadt M, et al. Altered function and connectivity of the medial frontal cortex in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010;68(11):1039-1047.
23. Cannistraro PA, Makris N, Howard JD, et al. A diffusion tensor imaging study of white matter in obsessivecompulsive disorder. Depress Anxiety. 2007;24(6):440-446.
24. Gruner P, Vo A, Ikuta T, et al. White matter abnormalities in pediatric obsessive-compulsive disorder. Neuropsychopharmacology. 2012;37(12):2730-2739.
25. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8(11):1481-1489.
26. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63(7):969-973.
27. Abosch A, Gupte A, Eberly LE, et al. Impulsive behavior and associated clinical variables in Parkinson's disease. Psychosomatics. 2011;52(1):41-47.
28. Grant JE, Donahue CB, Odlaug BL, et al. Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial. Br J Psychiatry. 2009;195(3):266-267.
29. Hodgins DC, Stea JN, Grant JE. Gambling disorders. Lancet. 2011 26;378(9806):1874-1884.
30. Grant JE, Odlaug BL, Mooney ME. Telescoping phenomenon in pathological gambling: association with gender and comorbidities. J Nerv Ment Dis. 2012;200(11):996-998.
31. Chambers RA, Potenza MN. Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud. 2003;19(1):53-84.
32. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry. 2007;20(3):255-261.
33. Chamberlain SR, Menzies L, Hampshire A, et al. Orbitofrontal dysfunction in patients with obsessivecompulsive disorder and their unaffected relatives. Science. 2008;321(5887):421-422.
34. Goudriaan AE, Oosterlaan J, De Beurs E, et al. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction. 2006;101(4):534-547.
35. Van Holst RJ, Van Den Brink W, Veltman DJ, et al. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev. 2010;34(1):87-107.
36. Lawrence AJ, Luty J, Bogdan NA, et al. Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl). 2009;207(1):163-172.
37. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001;110(3):482-487.
38. Potenza MN, Leung HC, Blumberg HP, et al. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003;160:1990-1994.
39. Grant JE, Potenza MN. Compulsive aspects of impulsecontrol disorders. Psychiatr Clin North Am. 2006;29(2):539-551.
40. Blaszczynski A. Pathological gambling and obsessive compulsive spectrum disorders. Psychol Rep. 1999;84:107-113.
41. Frost RO, Meagher BM, Riskind JH. Obsessive compulsive features in pathological lottery and scratchticket gamblers. J Gambl Stud. 2001;17:5-19.
42. Goudriaan AE, Oosterlaan J, De Beurs E, et al. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res. 2005;23(1):137-151.
43. Grant JE, Chamberlain SR, Odlaug BL, et al. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010;212(4):603-612.
44. Chamberlain SR, Fineberg NA, Blackwell AD, et al. Motor inhibition and cognitive flexibility in obsessivecompulsive disorder and trichotillomania. Am J Psychiatry. 2006;163(7):1282-1284.
45. Blanco C, Potenza MN, Kim SW, et al. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009;167(1-2):161-168.
46. Sanavio E. Obsessions and compulsions: the Padua Inventory. Behav Res Ther. 1988;26:169-177.
47. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. JAMA Psychiatry. 2003;60:828-836.
48. De Ruiter MB, Oosterlaan J, Veltman DJ, et al. Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug Alcohol Depend. 2012;121:81-89.
49. De Grack M, Enzi B, Prosch U, et al. Decreased neuronal activity in reward circuitry of pathological gamblers during processing of personal relevant stimuli. Hum Brain Mapp. 2010;31:1802-1812.
50. Miedl SF, Peters J, Buchel C. Altered neural reward representations in pathological gamblers revealed by delay and probability discounting. Arch Gen Psychiatry. 2012;69:177-186.
51. Kim SJ, Kang JI, Kim CH. Temperament and character in subjects with obsessive-compulsive disorder. Compr Psychiatry. 2009;50(6):567-572.
52. Del Casale A, Kotzalidis GD, Rapinesi C, et al. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology. 2011;64(2):61-85.
53. Chamberlain SR, Blackwell AD, Fineberg NA, et al. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005;29(3):399-419.
54. Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex. Trends Cogn Sci. 2004;8(4):170-177.
55. Veale DM, Sahakian BJ, Owen AM, et al. Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive-compulsive disorder. Psychol Med. 1996;26(6):1261-1269.
56. Ettelt S, Ruhrmann S, Barnow S, et al. Impulsiveness in obsessive-compulsive disorder: results from a family study. Acta Psychiatr Scand. 2007;115(1):41-47.
57. Fontenelle LF, Oostermeijer S, Harrison BJ, et al. Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments. Drugs. 2011;71(7):827-840.
58. Kashyap H, Fontenelle LF, Miguel EC, et al. "Impulsive compulsivity" in obsessive-compulsive disorder: a phenotypic marker of patients with poor clinical outcome. J Psychiatr Res. 2012;46(9):1146-1152.
59. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatmentrefractory obsessive-compulsive disorder. JAMA Psychiatry. 2010;67(10):1061-1068.
60. Grant JE, Odlaug BL, Chamberlain SR. Neurocognitive response to deep brain stimulation for obsessivecompulsive disorder: a case report. Am J Psychiatry. 2011;168(12):1338-1339.
61. Grant JE, Odlaug BL, Schreiber LR. Pharmacological treatments in pathological gambling. Br J Clin Pharmacol. In press. DOI: doi: 10.1111/j.1365-2125.2012.04457.x.
62. Verbeeck W, Tuinier S, Bekkering GE. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Adv Ther. 2009;26(2):170-184.
63. Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004;43(9):1146-1153.
64. Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther. 2011;132(3):314-332.
65. Chamberlain SR, Robbins TW. Noradrenergic modulation of cognition: therapeutic implications. J Psychopharmacol. In press.
66. Sansone RA, Sansone LA. SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder? Innov Clin Neurosci. 2011;8(6):10-14.
67. Franklin ME, Foa EB. Treatment of obsessive compulsive disorder. Annu Rev Clin Psychol. 2011;7:229-243.
68. McConaghy N, Armstrong MS, Blaszczynski A, et al. Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling. Br J Psychiatry. 1983;142:366-372.
69. Echeburua E, Baez C, Fernandez-Montalvo J. Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling: long-term outcome. Behavioural and Cognitive Psychotherapy. 1996;24:51-72.
70. Jimenez-Murcia S, Aymamí N, Gómez-Peña M, et al. Does exposure and response prevention improve the results of group cognitive-behavioural therapy for male slot machine pathological gamblers? Br J Clin Psychol. 2012;51:54-71.